RFK Jr. Dismisses CDC Vaccine Experts, Raising Public Health Concerns
TL;DR Summary
Shares of Moderna and Pfizer remained stable despite U.S. health secretary RFK Jr. firing CDC vaccine advisors, with the market already discounted due to vaccine skepticism and prior stock declines. The overhaul to the CDC's Advisory Committee on Immunization Practices poses risks to vaccine manufacturers, potentially affecting future vaccine recommendations and development costs, but the committee's continuation mitigates some concerns.
- Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.’s Firing of Vaccine Advisors. Barron's
- RFK Jr. Removes All CDC Vaccine Panel Experts The New York Times
- RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say CNBC
- Opinion | RFK Jr.: HHS Moves to Restore Public Trust in Vaccines WSJ
- RFK Jr. boots all members of the CDC's vaccine advisory committee NPR
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
1 min
vs 2 min read
Condensed
83%
356 → 60 words
Want the full story? Read the original article
Read on Barron's